Title: RelA inhibitors for Chronic Diseases
Abstract:
Biofilm infections have no approved effective medical treatments and can only be disrupted via physical means. In this work, we describe a hybrid in silico laboratory pipeline for identifying and validating small-molecule inhibitors of RelA for use in the combinatorial treatment of bacterial biofilms as re-potentiators of classical antibiotics.
